Search clinical trials for: CC-5103 (lenalidomide)

Total 7377 results

Celgene Corporation
Prologue Research International

Terminated

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.

Prostate Cancer

United States
Afyonkarahisar Health Sciences University

Completed

Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome

Musculoskeletal Diseases | Carpal Tunnel Syndrome | Median Nerve Disease | Ultrasound-Guided Injection

Turkey
Northwestern University
National Cancer Institute (NCI); Celgene

Active, not recruiting

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Peripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Cutaneous... and other conditions

United States
Medical University of Vienna
Fresenius Kabi

Completed

Crystalloids Versus Colloids During Surgery (CC)

Postoperative Complications | Fluid Overload

Austria
Shenyang Tenth People's Hospital
Beijing Tsinghua Changgeng Hospital

Not yet recruiting

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Advanced HCC
Jiangxi Provincial People's Hopital

Not yet recruiting

Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis

Dermatomyositis

China
Rabin Medical Center

Unknown

Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance

Patient Non-adherence
Celgene Corporation
Prologue Research International

Terminated

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
M.D. Anderson Cancer Center
Daiichi Sankyo

Recruiting

A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma

Lymphoma

United States
Celgene

Recruiting

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

Eosinophilic Esophagitis

United States
University of Washington
Cystic Fibrosis Foundation

Completed

A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

Cystic Fibrosis

United States
Zogenix MDS, Inc.

Completed

A RETROspective Study of Patients With TK2d (RETRO)

Thymidine Kinase 2 (TK2)

United States, Spain, Israel
Bristol-Myers Squibb

Completed

A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants

Healthy Participants

China
RAV Brabant MWN
Jeroen Bosch Ziekenhuis

Enrolling by invitation

A Feasibility Study for Elective Cardioversion of Atrial Fibrillation at Home (Electra-1)

Emergency Medical Services | Electric Countershock

Netherlands
Danish Headache Center

Completed

Validation of the TMD Pain Screener in a Specialized Headache Center

Headache Disorders | Temporomandibular Disorder

Denmark
Bristol-Myers Squibb

Active, not recruiting

A Rollover Study of CC-122

Non-Hodgkin Lymphoma

Netherlands, France, United States, Japan
Allina Health System

Active, not recruiting

Compass Course: COVID-19 (CC-COVID)

COVID-19

United States
Celgene

Completed

Relative Bioavailability Study of CC-292

Healthy Volunteers

United States
Celgene

Completed

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Healthy Volunteers

Belgium
Tactile Medical

Completed

Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.

Breast Cancer Lymphedema

United States
Cocrystal Pharma, Inc.

Completed

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

Hepatitis C

Canada
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

Hematologic Disorder

United States
Astellas Pharma Inc

Completed

Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

Irritable Bowel Syndrome With Constipation (IBS-C) | Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)

Japan
Oregon Research Institute
University of Oregon; Radboud University Medical Center; University of Exeter; Flinders...

Completed

Computerized Response Training Obesity Treatment (CC)

Obesity | Feeding and Eating Disorders | Hyperphagia

United States
Mansoura Integrated Fertility Center

Completed

Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS

Polycystic Ovary Syndrome

Egypt
University of Miami
National Institute on Disability, Independent Living, and Rehabilitation...

Completed

A Lifestyle Intervention Targeting Enhanced Health and Function for Persons With Chronic SCI in Caregiver/Care-Receiver Relationships: Effects of Caregiver Co-Treatment (DRPP)

Cardiovascular Diseases | Obesity | Spinal Cord Injury

United States
AHS Cancer Control Alberta
Alberta Cancer Foundation; Celgene Corporation

Completed

A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma

T-cell Lymphoma

Canada
University Hospital, Antwerp

Completed

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Atherosclerosis | Restenosis

Belgium
Celgene

Completed

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States, Canada, Japan, Poland, China, Czechia
Celgene

Completed

Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment

Hepatic Impairment

United States
International Medical University

Completed

Efficacy of tDNA Care on Weight Loss and Metabolic Outcomes in Patients With Overweight, Obesity and Type 2 Diabetes

Obesity | Diabetes

Malaysia
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Recruiting

Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

Multiple Myeloma

United States, Canada
Memorial Sloan Kettering Cancer Center
Celgene Corporation

Completed

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

Leukemia | Chronic Lymphocytic Leukemia

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaborators

Terminated

Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Leukemia

United States
University of Arkansas

Completed

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

Multiple Myeloma

United States
IRCCS Policlinico S. Matteo
Celgene Corporation

Completed

Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis

Amyloidosis

Italy
Celgene

Terminated

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

United States
University of Arkansas

Completed

Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II

Multiple Myeloma

United States
Roswell Park Cancer Institute
GlaxoSmithKline

Recruiting

Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant

Plasma Cell Myeloma

United States
Celgene

Recruiting

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

United States
Heilongjiang University of Chinese Medicine
The University of Hong Kong; Yale University; Jiangsu Province Hospital of Traditional... and other collaborators

Completed

Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome (PCOSAct)

Polycystic Ovary Syndrome | Infertility | Pregnancy

China
University of Rhode Island
Women and Infants Hospital of Rhode Island

Completed

18 Month Follow Up of Preterm Infants Enrolled in the Cord Clamping Study (18mo)

Developmental Delay

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
Amgen

Completed

A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The Netherlands (REWARD)

Arthritis, Psoriatic

Netherlands
Semnan University of Medical Sciences

Terminated

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

Polycystic Ovary Syndrome | Hyperandrogenism
Mohamed Sayed Abdelhafez

Completed

Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS

Infertility | Polycystic Ovarian Syndrome

Egypt
Jonsson Comprehensive Cancer Center

Recruiting

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

Prostate Carcinoma

United States
Kanuni Sultan Suleyman Training and Research Hospital

Unknown

Impact of Urethral Mobility on the Success of Sling Operations

Urinary Incontinence

Turkey
M.D. Anderson Cancer Center
Celgene Corporation

Terminated

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

Myeloma

United States
University of Colorado, Denver
Bristol-Myers Squibb

Recruiting

CC-486 and Venetoclax for Acute Myeloid Leukemia

AML

United States

Search clinical trials for: CC-5103 (lenalidomide)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations